Effects of folylpolyglutamate synthase modulation on global and gene-specific DNA methylation and gene expression in human colon and breast cancer cells

被引:8
作者
Kim, Sung-Eun [1 ,2 ]
Hinoue, Toshinori [3 ]
Kim, Michael S. [2 ]
Sohn, Kyoung-Jin [4 ]
Cho, Robert C. [1 ]
Weisenberger, Daniel J. [5 ,6 ]
Laird, Peter W.
Kim, Young-In [1 ,2 ,4 ,7 ]
机构
[1] Univ Toronto, Dept Nutr Sci, Toronto, ON M5S 1A8, Canada
[2] St Michaels Hosp, Keenan Res Ctr Biomed Sci, 209 Victoria St, Toronto, ON M5B 1T8, Canada
[3] Van Andel Res Inst, Ctr Epigenet, Grand Rapids, MI 49503 USA
[4] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada
[5] Univ So Calif, USC Epigenome Ctr, Los Angeles, CA 90089 USA
[6] Univ So Calif, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA
[7] St Michaels Hosp, Div Gastroenterol, Toronto, ON M5B 1W8, Canada
基金
加拿大健康研究院;
关键词
Folate; Folylpolyglutamate synthase (FPGS); DNA methylation; Gene expression; Colon cancer; Breast cancer; GAMMA-GLUTAMATE SYNTHETASE; THYMIDYLATE SYNTHASE; IN-VITRO; 5-FLUOROURACIL RESISTANCE; BIOCHEMICAL MODULATION; COLORECTAL-CANCER; THYMIDINE KINASE; FOLATE; CHEMOSENSITIVITY; CARCINOMA;
D O I
10.1016/j.jnutbio.2015.10.019
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Folylpolyglutamate synthase (FPGS) plays a critical role in intracellular folate homeostasis. FPGS-induced polyglutamylated folates are better substrates for several enzymes involved in the generation of S-adenosylmethionine, the primary methyl group donor, and hence FPGS modulation may affect DNA methylation. DNA methylation is an important epigenetic determinant in gene expression and aberrant DNA methylation is mechanistically linked cancer development. We investigated whether FPGS modulation would affect global and gene-specific promoter DNA methylation with consequent functional effects on gene expression profiles in HCT116 colon and MDA-MB-435 breast cancer cells. Although FPGS modulation altered global DNA methylation and DNA methyltransferases (DNMT) activity, the effects of FPGS modulation on global DNA methylation and DNMT activity could not be solely explained by intracellular folate concentrations and content of long-chain folylpolyglutamates, and it may be cell-specific. FPGS modulation influenced differential gene expression and promoter cytosine-guanine dinucleotide sequences (CpG) DNA methylation involved in cellular development, cell cycle, cell death and molecular transport. Some of the altered gene expression was associated with promoter CpG DNA methylation changes. In both the FPGS-overexpressed HCT116 and MDA-MB-435 cell lines, we identified several differentially expressed genes involved in folate biosynthesis and one-carbon metabolism, which might in part have contributed to the observed increased efficacy of 5-fluorouracil in response to FPGS overexpression. Our data suggest that FPGS modulation affects global and promoter CpG DNA methylation and expression of several genes involved in important biological pathways. The potential role of FPGS modulation in DNA methylation and its associated downstream functional effects warrants further studies. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:27 / 35
页数:9
相关论文
共 48 条
  • [1] Folylpolyglutamyl synthetase gene transfer and glioma antifolate sensitivity in culture and in vivo
    Aghi, M
    Kramm, CM
    Breakefield, XO
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (14) : 1233 - 1241
  • [2] Genome-wide DNA methylation profiling using Infinium® assay
    Bibikova, Marina
    Le, Jennie
    Barnes, Bret
    Saedinia-Melnyk, Shadi
    Zhou, Lixin
    Shen, Richard
    Gunderson, Kevin L.
    [J]. EPIGENOMICS, 2009, 1 (01) : 177 - 200
  • [3] Relevance of tumoral folylpolyglutamate synthetase and reduced folates for optimal 5-fluorouracil efficacy: Experimental data
    Cheradame, S
    Etienne, MC
    Chazal, M
    Guillot, T
    Fischel, JL
    Formento, P
    Milano, G
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 (06) : 950 - 959
  • [4] Effects of folate and folyipolyglutamyl synthase modulation on chemosensitivity of breast cancer cells
    Cho, Robert C.
    Cole, Peter D.
    Sohn, KyOung-Jin
    Gaisano, Gregory
    Croxford, Ruth
    Kamen, Barton A.
    Kim, Young-In
    [J]. MOLECULAR CANCER THERAPEUTICS, 2007, 6 (11) : 2909 - 2920
  • [5] Blockade of phospholipid scramblase 1 with its N-terminal domain antibody reduces tumorigenesis of colorectal carcinomas in vitro and in vivo
    Fan, Chung-Wei
    Chen, Chun-Yu
    Chen, Kuei-Tien
    Shen, Chia-Rui
    Kuo, Yung-Bin
    Chen, Ya-Shan
    Chou, Yeh-Pin
    Wei, Wei-Shan
    Chan, Err-Cheng
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2012, 10
  • [6] Genetic and biochemical modulation of 5-fluorouracil through the overexpression of thymidine kinase: an in-vitro study
    Fanciullino, Raphaelle
    Evrard, Alexandre
    Cuq, Pierre
    Giacometti, Sarah
    Peillard, Laurent
    Mercier, Cedric
    Aubert, Claude
    Milano, Gerard
    Ciccolini, Joseph
    [J]. ANTI-CANCER DRUGS, 2006, 17 (04) : 463 - 470
  • [7] C1s, the protease messenger of C1 -: Structure, function and physiological significance
    Gál, P
    Ambrus, G
    Závodszky, P
    [J]. IMMUNOBIOLOGY, 2002, 205 (4-5) : 383 - 394
  • [8] Down-regulation of ALDH1A3, CD44 or MDR1 sensitizes resistant cancer cells to FAK autophosphorylation inhibitor Y15
    Golubovskaya, Vita
    O'Brien, Shalana
    Ho, Baotran
    Heffler, Melissa
    Conroy, Jeffrey
    Hu, Quang
    Wang, Dan
    Liu, Song
    Cance, William G.
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (09) : 1613 - 1631
  • [9] ATP-Binding Cassette C Transporters in Human Pancreatic Carcinoma Cell Lines
    Hagmann, Wolfgang
    Jesnowski, Ralf
    Faissner, Ralf
    Guo, Changqing
    Lohr, J. Matthias
    [J]. PANCREATOLOGY, 2009, 9 (1-2) : 136 - 144
  • [10] Mechanisms of disease: Gene silencing in cancer in association with promoter hypermethylation
    Herman, JG
    Baylin, SB
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (21) : 2042 - 2054